MASSA, FEDERICO
 Distribuzione geografica
Continente #
EU - Europa 6.651
AS - Asia 1.228
NA - Nord America 616
SA - Sud America 121
AF - Africa 25
OC - Oceania 4
Totale 8.645
Nazione #
IT - Italia 6.450
US - Stati Uniti d'America 586
SG - Singapore 487
VN - Vietnam 297
CN - Cina 294
BR - Brasile 73
HK - Hong Kong 54
FR - Francia 52
FI - Finlandia 31
GB - Regno Unito 30
DE - Germania 22
AR - Argentina 17
CA - Canada 14
MX - Messico 13
JP - Giappone 10
PK - Pakistan 10
BD - Bangladesh 9
ID - Indonesia 9
IQ - Iraq 9
IE - Irlanda 8
EC - Ecuador 7
IN - India 7
NL - Olanda 7
UA - Ucraina 7
CL - Cile 6
CO - Colombia 6
RU - Federazione Russa 6
TW - Taiwan 6
ZA - Sudafrica 6
AT - Austria 5
ES - Italia 5
PH - Filippine 5
PL - Polonia 5
PS - Palestinian Territory 5
TN - Tunisia 5
TR - Turchia 5
AU - Australia 4
KE - Kenya 4
SE - Svezia 4
VE - Venezuela 4
CH - Svizzera 3
MA - Marocco 3
RS - Serbia 3
UZ - Uzbekistan 3
BO - Bolivia 2
DK - Danimarca 2
GR - Grecia 2
IL - Israele 2
JO - Giordania 2
OM - Oman 2
PE - Perù 2
PY - Paraguay 2
SA - Arabia Saudita 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AZ - Azerbaigian 1
BE - Belgio 1
BH - Bahrain 1
CI - Costa d'Avorio 1
CY - Cipro 1
DZ - Algeria 1
EG - Egitto 1
GA - Gabon 1
HR - Croazia 1
IS - Islanda 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LT - Lituania 1
MT - Malta 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
PR - Porto Rico 1
PT - Portogallo 1
RO - Romania 1
SI - Slovenia 1
SN - Senegal 1
SV - El Salvador 1
TH - Thailandia 1
TZ - Tanzania 1
ZW - Zimbabwe 1
Totale 8.645
Città #
Genoa 3.410
Genova 1.533
Vado Ligure 817
Rapallo 474
Singapore 229
San Jose 175
Ho Chi Minh City 105
Ashburn 95
Hanoi 69
Hong Kong 52
Lauterbourg 43
Beijing 41
Council Bluffs 40
Bordighera 29
Helsinki 26
Santa Clara 23
Los Angeles 20
New York 20
Frankfurt am Main 19
Milan 16
Rome 15
Orem 13
St Louis 11
Tokyo 10
Chicago 9
Bologna 8
Haiphong 8
Pisa 8
São Paulo 8
City of London 7
Da Nang 7
Dublin 7
Buffalo 6
Hải Dương 6
Marseille 6
Mexico City 6
Naples 6
Phủ Lý 6
Atlanta 5
Florence 5
Johannesburg 5
Lappeenranta 5
Montreal 5
Quito 5
Savona 5
Toronto 5
Cardiff 4
Denver 4
Jakarta 4
Karachi 4
London 4
Pavia 4
Poplar 4
Warsaw 4
Amsterdam 3
Bari 3
Belgrade 3
Biên Hòa 3
Buenos Aires 3
Bắc Ninh 3
Bến Tre 3
Ha Long 3
Istanbul 3
Lahore 3
Madrid 3
Ninh Bình 3
Piscataway 3
San Francisco 3
Santiago 3
Thái Bình 3
Tunis 3
Turin 3
Vienna 3
Acalanes Ridge 2
Alessandria 2
Baghdad 2
Bentonville 2
Brescia 2
Brisbane 2
Buon Ma Thuot 2
Cairo 2
Can Tho 2
Chengdu 2
Cochabamba 2
Copenhagen 2
Cotia 2
Dhaka 2
Faisalabad 2
Go Vap 2
Guangzhou 2
Guayaquil 2
Hortolândia 2
Houston 2
Jaboatão dos Guararapes 2
Kyiv 2
Lancaster 2
Lombard 2
Lviv 2
Manchester 2
Medellín 2
Totale 7.566
Nome #
Spinocerebellar ataxia 17: full phenotype in a 41 CAG/CAA repeats carrier. 197
Accuracy and generalization capability of an automatic method for the detection of typical brain hypometabolism in prodromal Alzheimer disease 182
Added value of semiquantitative analysis of brain FDG-PET for the differentiation between MCI-Lewy bodies and MCI due to Alzheimer’s disease 176
Head-to-Head Comparison among Semi-Quantification Tools of Brain FDG-PET to Aid the Diagnosis of Prodromal Alzheimer's Disease 175
Prediction of cognitive worsening in de novo Parkinson's disease: Clinical use of biomarkers 173
Striatal dopamine transporter SPECT quantification: head-to-head comparison between two three-dimensional automatic tools 164
The fate of patients with REM sleep behavior disorder and Mild Cognitive Impairment 160
Metabolic correlates of reserve and resilience in MCI due to Alzheimer's Disease (AD) Rik Ossenkoppele 158
Serum neurofilament light chain rate of change in Alzheimer's disease: potentials applications and notes of caution 156
Brain Resources: How Semantic Cueing Works in Mild Cognitive Impairment due to Alzheimer’s Disease (MCI-AD) 149
Neuroimaging findings and clinical trajectories of Lewy body disease in patients with MCI 147
Could arterial spin labelling perfusion imaging uncover the invisible in N-methyl-d-aspartate receptor encephalitis? 143
Epilepsy in Neurodegenerative Dementias: A Clinical, Epidemiological, and EEG Study 141
How can we define a brain health chart? A narrative review and a proposal 139
Cerebrospinal fluid NPTX2 changes and relationship with regional brain metabolism metrics across mild cognitive impairment due to Alzheimer's disease 138
Cuneus/precuneus as a central hub for brain functional connectivity of mild cognitive impairment in idiopathic REM sleep behavior patients 138
Anatomical and neurochemical bases of theory of mind in de novo Parkinson's Disease 135
Clinical and MRI Predictors of Conversion From Mild Behavioural Impairment to Dementia 133
Limbic Network Derangement Mediates Unawareness of Apathy in Mild Cognitive Impairment due to Alzheimer’s Disease: Clues from [18F]FDG PET Voxel-Wise Analysis 131
Bendamustine-rituximab (BR) combined therapy for treatment of immuno-mediated neuropathies associated with hematologic malignancy. 131
Brain metabolic correlates of persistent olfactory dysfunction after sars-cov2 infection 130
Getting the high school diploma with only one hemisphere: a case report 129
Utility of quantitative EEG in early Lewy body disease 126
The role of anterior prefrontal cortex in prospective memory: an exploratory FDG-PET study in early Alzheimer's disease 122
A case series of parainfectious Guillain-Barré syndrome linked to influenza A (H1N1) virus infection 122
Case Report: Post-COVID-19 Vaccine Recurrence of Guillain-Barré Syndrome Following an Antecedent Parainfectious COVID-19-Related GBS 122
Neuroimaging Findings in Mild Cognitive Impairment 116
FDG-PET and ASL MRI identify largely overlapping hypermetabolic and hyperperfusion changes in limbic autoimmune encephalitis 115
The Free and Cued Selective Reminding Test: Discriminative Values in a Naturalistic Cohort 115
Clinical and biological underpinnings of longitudinal atrophy pattern progression in Alzheimer's disease 112
Increased incidence of axonal Guillain-Barré syndrome in La Spezia area of Italy: A 13-year follow-up study 111
The Role of Hub and Spoke Regions in Theory of Mind in Early Alzheimer’s Disease and Frontotemporal Dementia 110
Tracking the progression of Alzheimer's disease: Insights from metabolic patterns of SOMI stages 108
Clinical utility and research frontiers of neuroimaging in movement disorders 107
Importance of intensive and prolonged rehabilitative treatment on the Guillain-Barrè syndrome long-term outcome: a retrospective study 107
Subgroup comparison according to clinical phenotype and serostatus in autoimmune encephalitis: a multicenter retrospective study 107
REMeDio: a proof-of-concept neuroprotection study for prodromal synucleinopathies 104
FDG PET Unveils the Course of Paraneoplastic Cerebellar Degeneration: A Semiquantitative Analysis 103
Reciprocal Incremental Value of 18F-FDG-PET and Cerebrospinal Fluid Biomarkers in Mild Cognitive Impairment Patients Suspected for Alzheimer's Disease and Inconclusive First Biomarker 101
Sex differences in neuroimaging biomarkers in healthy subjects and dementia 100
Stratification Tools for Disease-Modifying Trials in Prodromal Synucleinopathy 100
Clinical and metabolic profiles in behavioural frontotemporal dementia: Impact of age at onset 99
WHAT MAINTENANCE THERAPY TO PERFORM IN PATIENTS WITH ANTI-MAG NEUROPATHY AFTER THE FIRST CYCLE OF RITUXIMAB? A COMPARISON BETWEEN TWO REGIMENS 98
N-methyl-D-aspartate receptor antibody-related pathologies and pre-existent mental state disorders 98
Dopaminergic and Serotonergic Degeneration and Cortical [18 F]Fluorodeoxyglucose Positron Emission Tomography in De Novo Parkinson's Disease 98
Different z-score cut-offs for striatal binding ratio (SBR) of DaT SPECT are needed to support the diagnosis of Parkinson’s Disease (PD) and dementia with Lewy bodies (DLB) 97
Abnormal sweating and “skin flushing” as possible predictive factor for treatment related fluctuations in Guillain-Barré syndrome: a case series and a review of the literature 96
Neurological long-COVID in the outpatient clinic: Two subtypes, two courses 96
A case of Huntington disease-like 2 in a patient of African ancestry: the everlasting support of clinical examination in the molecular era 94
Polysomnographic correlates of sleep disturbances in de novo, drug naïve Parkinson's Disease 93
Derivation and Validation of a Phenoconversion-Related Pattern in Idiopathic Rapid Eye Movement Behavior Disorder 87
Metabolic and dopaminergic correlates of intellectual enrichment in de-novo Parkinson's disease patients 84
Magnetic susceptibility components reveal different aspects of neurodegeneration in alpha-synucleinopathies 82
Discrepancy Between Patient and Caregiver Estimate of Apathy Predicts Dementia in Patients with Amnestic Mild Cognitive Impairment 81
Incident anti-LGI1 autoimmune encephalitis during dementia with Lewy bodies: when Occam razor is a double-edged sword 81
Alzheimer's disease (AD) co-pathology in dementia with Lewy bodies (DLB): implications in the disease modification era 80
Cerebrospinal Fluid Biomarkers Profiling in Cerebral Amyloid Angiopathy and Relationship With Disease Phenotypes 80
Investigating interleukin-8 in Alzheimer's disease: A comprehensive review 80
Compressed sensing (CS) MP2RAGE versus standard MPRAGE: A comparison of derived brain volume measurements 79
Anti-LGI1 encephalitis and Langerhans cell histiocytosis: two associated entities? A case report 77
Outcomes after single-cycle rituximab monotherapy in patients with anti-MAG polyneuropathy: A bi-center experience with an average follow-up of 11 years 75
COVID-19-associated serum and cerebrospinal fluid cytokines in post- versus para-infectious SARS-CoV-2-related Guillain–Barré syndrome 70
Cognitive and Brain Metabolism Profiles of Mild Cognitive Impairment in Prodromal Alpha-Synucleinopathy 70
The Role of Monoaminergic Tones and Brain Metabolism in Cognition in~de~novo Parkinson's Disease 69
Exploring the brain metabolic correlates of process-specific CSF biomarkers in patients with MCI due to Alzheimer's disease: preliminary data 68
18F-FDG-PET/CT (FDG-PET) in Neurodegenerative Disease 68
Autoimmune encephalitis: what the radiologist needs to know 66
Cerebrospinal fluid β-synuclein as a synaptic biomarker for preclinical Alzheimer's disease 63
Toward Quantitative Neurology: Sensors to Assess Motor Deficits in Dementia 62
Intravenous immunoglobulin bridging to rituximab in NMDAR encephalitis patients non-responders to first-line treatments 61
Machine learning based analysis of FDG-PET image data for the diagnosis of neurodegenerative diseases 60
Integrating cerebrospinal fluid and [18F]-fluorodeoxyglucose positron emission tomography to diagnose Alzheimer's disease and research its pathophysiological substrates 58
[18F]FDG PET metabolic correlates of cerebrospinal fluid TAR DNA-binding protein 43 in prodromal Alzheimer's disease 57
Presynaptic Dopaminergic Imaging Characterizes Patients with REM Sleep Behavior Disorder Due to Synucleinopathy 55
Case 4: Parkinson’s Disease with Onset as Mild Cognitive Impairment (MCI) 55
Validation of the REM behaviour disorder phenoconversion-related pattern in an independent cohort 54
Diagnostic and prognostic value of dual-point amyloid PET in Alzheimer’s disease (AD) mimickers 50
Clinical and diagnostic implications of Alzheimer’s disease copathology in Lewy body disease 49
Ma2 antibody-associated limbic encephalitis: The early etiology treatment may modify the disease clinical trajectory 48
Abnormal electroencephalographic rhythms from quiet wakefulness to light sleep in Alzheimer's disease patients with mild cognitive impairment 46
null 41
CSF IL-6, GDF-15, GFAP and NfL levels in early Alzheimer disease: a pilot study 38
Longitudinal changes in [18F]FDG PET brain metabolism as a prognostic marker in autoimmune encephalitis 38
Editorial: CSF and blood biomarkers in COVID-19 and other neuroinfectious diseases 37
Clinical versus biomarker-based diagnosis of neurocognitive disorders – Authors' reply 35
Progression trajectories from prodromal to overt synucleinopathies: a longitudinal, multicentric brain [18F]FDG-PET study 31
Right posterior hypometabolism in Pisa syndrome of Parkinson's disease: A key to explain body schema perception deficit? 31
European consensus for the diagnosis of MCI and mild dementia: Preparatory phase 30
Neuropsychological and clinical variables associated with cognitive trajectories in patients with Alzheimer's disease 28
Rituximab retreatment guided by CD27+ B-cell count vs. clinical relapse in anti-MAG polyneuropathy: a cost-effective approach with lower cumulative doses 27
Uncovering Clinical and Functional Neuroimaging Characteristics of Overt Stage Phenotypes Within the α-Synucleinopathy Spectrum 26
Relationship between default mode network and resting-state electroencephalographic alpha rhythms in cognitively unimpaired seniors and patients with dementia due to alzheimer’s disease 25
CSF Synaptic Biomarkers in AT(N)-Based Subgroups of Lewy Body Disease 21
Diagnostic performance of molecular imaging methods in predicting the progression from mild cognitive impairment to dementia: an updated systematic review 21
Clinical Pathways for Diagnosing Neurocognitive Disorders: Insights From Process Mining a Memory Clinic Cohort 20
European intersocietal recommendations for the biomarker-based diagnosis of neurocognitive disorders 20
Resting-State EEG Alpha Rhythms Are Related to CSF Tau Biomarkers in Prodromal Alzheimer’s Disease 15
Specific Cerebrospinal Fluid SerpinA1 Isoform Pattern in Alzheimer’s Disease 14
Sex differences in brain atrophy in dementia with Lewy bodies 14
The compensatory effect of education as revealed by resting-state electroencephalographic alpha rhythms in patients with dementia due to Parkinson’s disease: findings from an exploratory study 14
Totale 8.843
Categoria #
all - tutte 31.688
article - articoli 29.944
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.479
Totale 63.111


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021104 0 0 0 0 0 0 0 0 0 55 21 28
2021/2022495 28 5 8 35 29 40 23 92 45 84 30 76
2022/2023561 40 60 8 51 70 70 7 49 85 22 84 15
2023/2024613 47 47 13 94 49 100 44 46 24 26 34 89
2024/20252.337 103 116 65 194 228 246 220 412 116 122 238 277
2025/20263.747 608 185 264 318 531 234 536 272 385 414 0 0
Totale 8.920